Avascular necrosis of the proximal humerus: a novel indication for the use of osteochondral allograft transplantation in the shoulder: Case report.

Avascular necrosis Osteochondral allograft Proximal humerus Shoulder Transplantation

Journal

Journal of ISAKOS : joint disorders & orthopaedic sports medicine
ISSN: 2059-7762
Titre abrégé: J ISAKOS
Pays: England
ID NLM: 101680867

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 17 11 2022
revised: 14 02 2023
accepted: 27 07 2023
pubmed: 13 8 2023
medline: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

Osteochondral allograft (OCA) transplantation is an increasingly available biologic treatment option for a range of intraarticular aetiologies. To our knowledge, no prior publication has documented the use of this technology to treat a lesion of the proximal humerus secondary to avascular necrosis (AVN). We describe our experience treating a 42-year-old female executive with idiopathic AVN of the proximal humerus with a fresh osteochondral allograft. Computed tomography (CT) at 3 months post-op showed full bony incorporation and a restored native joint contour. Over the initial 7 months post-operatively, she reported continued improvements in pain and function as measured by quick Disabilities of the Arm, Shoulder, and Hand (DASH) scores. She was discharged from physical therapy after 6 months, reporting no rest pain, full active and passive range of motion, and unrestricted occupational and recreational activity.

Identifiants

pubmed: 37572786
pii: S2059-7754(23)00546-1
doi: 10.1016/j.jisako.2023.07.011
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

387-391

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dennis Crawford, MD, PhD reports financial support was provided by Joint Restoration Foundation, Inc. Dennis Crawford, MD, PhD reports financial support was provided by Moximed. Dennis Crawford, MD, PhD reports financial support was provided by Aesculap Biologics. Dennis Crawford, MD, PhD reports financial support was provided by CartiHeal LTD. Dennis Crawford, MD, PhD reports financial support was provided by Zimmer Biologics, Inc. Dennis Crawford, MD, PhD reports a relationship with Community Tissue Services, Inc. that includes: consulting or advisory. Dennis Crawford, MD, PhD reports a relationship with Moximed that includes: consulting or advisory. Dennis Crawford, MD, PhD reports a relationship with Joint Restoration Foundation, Inc. that includes: consulting or advisory. Dennis Crawford, MD, PhD reports a relationship with Vericel Corp that includes: consulting or advisory. Dennis Crawford, MD, PhD reports a relationship with Joint Restoration Foundation, Inc. that includes: speaking and lecture fees. Dennis Crawford, MD, PhD reports a relationship with Steelhead Surgical that includes: speaking and lecture fees. Dennis Crawford, MD, PhD reports a relationship with Arthrex, Inc that includes: speaking and lecture fees. Suzanne Tabbaa, PhD reports a relationship with JRF Ortho that includes: consulting or advisory.

Auteurs

Brian Prigmore (B)

OHSU Department of Orthopaedics & Rehabilitation, Center for Health & Healing, Building 1, 12th Floor 3303 S. Bond Avenue Portland, OR 97239, USA.

Suzanne Tabbaa (S)

UCSF School of Medicine, Department of Orthopaedic Surgery, 1001 Potrero Ave, San Francisco, CA 94110, USA.

Dennis C Crawford (DC)

OHSU Department of Orthopaedics & Rehabilitation, Center for Health & Healing, Building 1, 12th Floor 3303 S. Bond Avenue Portland, OR 97239, USA. Electronic address: crawfden@ohsu.edu.

Classifications MeSH